13 Results for "

Niclosamide monohydrate

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "Niclosamide monohydrate" in MCE Product Catalog:

42
42 Publications Verification
Cat. No.: HY-B0497
CAS No.: 50-65-7
Synonyms: BAY2353
Niclosamide (BAY2353) is an orally active antihelminthic agent used in parasitic infection research . Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide has biological activities against cancer, inhibits DNA replication in Vero E6 cells .
42
42 Publications Verification
Cat. No.: HY-B0497C
CAS No.: 1420-04-8
Synonyms: BAY2353 olamine
Niclosamide (BAY2353) olamine is an orally active antihelminthic agent used in parasitic infection research . Niclosamide olamin is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide olamin has biological activities against cancer, and inhibits DNA replication in Vero E6 cells .
Cat. No.: HY-B0497R
CAS No.: 50-65-7
Synonyms: BAY2353 (Standard)
Research Areas:  

Infection Cancer

Niclosamide (Standard) is the analytical standard of Niclosamide. This product is intended for research and analytical applications. Niclosamide (BAY2353) is an orally active antihelminthic agent used in parasitic infection research . Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide has biological activities against cancer, inhibits DNA replication in Vero E6 cells .
Cat. No.: HY-144772
CAS No.: 1580-42-3
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-15 (compound 11) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.49 μM. SARS-CoV-2-IN-15 is a niclosamide analogue. SARS-CoV-2-IN-15 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally .
Cat. No.: HY-B0497B
CAS No.: 73360-56-2
Synonyms: BAY2353 monohydrate
Target:  

STAT Antibiotic Parasite

Research Areas:  

Infection Cancer

Niclosamide (BAY2353) monohydrate is an orally active antihelminthic agent used in parasitic infection research . Niclosamide monohydrate is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide monohydrate has biological activities against cancer, and inhibits DNA replication in Vero E6 cells .
Cat. No.: HY-B0497S1
CAS No.: 1325808-64-7
Synonyms: BAY2353-13C6
Niclosamide- 13C6 is the 13C6 labeled Niclosamide. Niclosamide (BAY2353) is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 μM in HeLa cells and inhibits DNA replication in a cell-free assay.
Cat. No.: HY-144770
CAS No.: 56961-10-5
Purity:  98.90%
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-13 (compound 5) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.057 μM. SARS-CoV-2-IN-13 is a niclosamide analogue. SARS-CoV-2-IN-13 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally .
Cat. No.: HY-B0497A
CAS No.: 40321-86-6
Synonyms: BAY2353 sodium
Target:  

Antibiotic STAT Parasite

Research Areas:  

Infection Cancer

Niclosamide (BAY2353) sodium is an orally active antihelminthic agent used in parasitic infection research . Niclosamide sodium is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide sodium has biological activities against cancer, and inhibits DNA replication in Vero E6 cells .
Cat. No.: HY-B0497S2
CAS No.: 2665663-60-3
Synonyms: BAY2353-d3
Niclosamide-d3 (BAY2353-d3) is deuterium labeled Niclosamide. Niclosamide (BAY2353) is an orally active antihelminthic agent used in parasitic infection research . Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide has biological activities against cancer, inhibits DNA replication in Vero E6 cells .
Cat. No.: HY-B0497G
CAS No.: 50-65-7
Synonyms: BAY2353 (GMP)
Niclosamide (GMP) is Niclosamide (HY-B0497) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Niclosamide (BAY2353) is an orally active antihelminthic agent used in parasitic infection research . Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide has biological activities against cancer, inhibits DNA replication in Vero E6 cells .
Cat. No.: HY-B0497BS
CAS No.: 1325559-12-3
Synonyms: BAY2353-13C6 monohydrate
Niclosamide- 13C6 (monohydrate) is the 13C labeled Niclosamide monohydrate . Niclosamide (BAY2353) monohydrate is an orally active antihelminthic agent used in parasitic infection research . Niclosamide monohydrate is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide monohydrate has biological activities against cancer, and inhibits DNA replication in Vero E6 cells .
Cat. No.: HY-B0497CR
CAS No.: 1420-04-8
Synonyms: BAY2353 olamine (Standard)
Research Areas:  

Infection Cancer

Crocin (Standard) is the analytical standard of Crocin. This product is intended for research and analytical applications. Crocin (Crocin I) is an orally active natural product that can be isolated from the stigma of Crocus sativus. Crocin inhibits tumor cell proliferation and promotes apoptosis through JAK pathway. Crocin has anti-inflammatory, antioxidant and antitumor activities .
Cat. No.: HY-144771
CAS No.: 22203-98-1
Purity:  99.02%
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally .
  • 1